Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

Contributed by: ACCESS Newswire

Logo

Tags

Healthcare & Pharmaceutical

Moderna, Inc.

NASDAQ:MRNA

Company Update

More Like This

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

National RSV vaccination programme announced

New RSV vaccine could prevent 5,000 infant hospitalisations

Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine